IMAX (IMAX) Financials

$25.06 +0.72 (+2.97%)

Closing price 03:59 PM Eastern

Extended Trading

$24.70 -0.36 (-1.44%)

As of 06:12 PM Eastern

Annual Income Statements for IMAX

This table shows IMAX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	40	56	29	2.34	23	47	-144	-22	-23	25	26
Consolidated Net Income / (Loss)	42	65	39	13	34	59	-157	-9.58	-20	33	33
Net Income / (Loss) Continuing Operations	42	65	39	13	34	59	-157	-9.58	-20	33	33
Total Pre-Tax Income	57	87	58	30	44	75	-129	11	-9.77	46	38
Total Operating Income	58	88	59	31	45	77	-122	11	-4.83	50	44
Total Gross Profit	173	219	203	185	205	212	2.33	134	156	214	190
Total Revenue	291	374	377	381	374	396	137	255	301	375	352
Operating Revenue	291	374	377	381	374	396	137	255	301	375	352
Total Cost of Revenue	117	155	175	196	170	184	135	117	144	160	162
Operating Cost of Revenue	117	155	175	196	166	181	116	120	144	160	162
Total Operating Expenses	116	132	144	154	160	134	125	127	161	164	146
Selling, General & Admin Expense	93	115	124	110	117	123	108	117	138	144	133
Research & Development Expense	16	13	16	21	14	5.20	5.62	6.94	5.30	10	5.10
Amortization Expense	1.72	1.86	2.08	3.02	4.15	4.96	5.39	4.88	4.83	4.58	5.76
Other Operating Expenses / (Income)	0.92	0.75	0.95	2.65	2.99	-	-	-	8.55	1.76	-0.97
Impairment Charge	3.52	0.83	0.42	1.23	0.00	0.00	1.15	0.00	4.47	0.14	0.00
Restructuring Charge	-	0.00	0.00	16	9.54	0.85	0.00	0.00	0.00	2.95	3.75
Total Other Income / (Expense), net	-0.52	-0.69	-0.74	-1.43	-1.57	-1.94	-6.70	0.00	-4.94	-4.28	-6.16
Interest Expense	0.92	1.66	2.23	1.94	2.92	3.53	7.01	7.09	6.43	7.23	8.47
Interest & Investment Income	-	-	-	1.03	1.84	1.59	0.31	7.56	1.50	2.95	2.31
Income Tax Expense	14	20	16	17	9.52	17	27	21	10	13	5.00
Net Income / (Loss) Attributable to Noncontrolling Interest	2.43	8.78	11	10	11	12	-14	13	2.92	7.73	6.64
Basic Earnings per Share	$0.58	$0.79	$0.43	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.47	$0.49
Weighted Average Basic Shares Outstanding	68.50M	70.70M	66.90M	58.60M	61.48M	61.36M	59.24M	59.13M	56.67M	54.31M	52.65M
Diluted Earnings per Share	$0.56	$0.78	$0.42	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.46	$0.48
Weighted Average Diluted Shares Outstanding	68.50M	70.70M	66.90M	58.60M	61.48M	61.36M	59.24M	59.13M	56.67M	55.15M	53.86M
Weighted Average Basic & Diluted Shares Outstanding	68.50M	70.70M	66.90M	58.60M	61.48M	61.36M	58.95M	58.58M	53.97M	52.95M	53.02M

This table shows IMAX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-8.95	2.61	2.45	8.35	12	2.54	3.27	3.58	14	5.31	2.33
Consolidated Net Income / (Loss)	-7.76	4.08	5.12	9.61	15	3.31	5.42	5.07	15	6.87	8.15
Net Income / (Loss) Continuing Operations	-7.76	4.08	5.12	9.61	15	3.31	5.42	5.07	15	6.87	8.15
Total Pre-Tax Income	-5.41	6.10	10	13	22	1.46	11	1.08	18	8.32	15
Total Operating Income	-4.24	7.54	11	14	22	2.74	12	2.87	19	9.51	17
Total Gross Profit	32	56	50	58	63	44	47	44	51	48	53
Total Revenue	69	98	87	98	104	86	79	89	91	93	87
Operating Revenue	69	98	87	98	104	86	79	89	91	93	87
Total Cost of Revenue	38	41	37	40	41	42	32	45	40	44	33
Operating Cost of Revenue	37	49	37	40	41	42	32	45	40	44	33
Total Operating Expenses	35	49	38	44	41	41	35	41	32	39	37
Selling, General & Admin Expense	33	38	34	39	36	35	31	38	31	32	33
Research & Development Expense	1.12	1.63	1.86	2.76	2.77	2.72	2.19	2.03	-0.27	1.15	1.32
Amortization Expense	1.11	1.42	1.07	1.15	1.11	1.25	1.34	1.32	1.54	1.55	1.73
Restructuring Charge	-	-	1.35	0.00	0.00	1.59	0.00	0.00	0.00	3.75	0.06
Total Other Income / (Expense), net	-1.17	-1.44	-1.39	-1.15	-0.46	-1.28	-1.49	-1.80	-1.69	-1.19	-1.30
Interest Expense	1.32	1.80	1.84	1.80	1.56	2.03	1.95	2.28	2.35	1.90	1.80
Interest & Investment Income	0.29	0.22	0.45	0.72	1.10	0.68	0.56	0.59	0.66	0.49	0.57
Other Income / (Expense), net	-0.14	-	-	-0.08	-	-	-0.11	-0.11	-	-	-0.07
Income Tax Expense	2.35	2.02	4.89	3.46	6.56	-1.85	5.16	-4.00	2.38	1.46	7.29
Net Income / (Loss) Attributable to Noncontrolling Interest	1.20	1.47	2.67	1.26	3.03	0.77	2.15	1.49	1.45	1.56	5.82
Basic Earnings per Share	($0.16)	$0.04	$0.05	$0.15	$0.22	$0.05	$0.06	$0.07	$0.26	$0.10	$0.04
Weighted Average Basic Shares Outstanding	56.04M	56.67M	54.06M	54.59M	54.62M	54.31M	52.50M	52.63M	52.68M	52.65M	53.15M
Diluted Earnings per Share	($0.16)	$0.04	$0.04	$0.15	$0.22	$0.05	$0.06	$0.07	$0.26	$0.09	$0.04
Weighted Average Diluted Shares Outstanding	56.04M	56.67M	54.99M	55.32M	55.54M	55.15M	53.41M	53.43M	54.09M	53.86M	54.97M
Weighted Average Basic & Diluted Shares Outstanding	55.97M	53.97M	54.59M	54.62M	54.61M	52.95M	52.62M	52.68M	52.68M	53.02M	53.74M

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	77	211	-113	-46	-17	-32	208	-128	-92	-21	24
Net Cash From Operating Activities	87	84	78	85	110	90	-23	6.07	17	59	71
Net Cash From Continuing Operating Activities	125	114	122	85	110	90	-23	6.07	17	59	71
Net Income / (Loss) Continuing Operations	42	65	39	13	34	59	-157	-9.58	-20	33	33
Consolidated Net Income / (Loss)	42	65	39	13	34	59	-157	-9.58	-20	33	33
Depreciation Expense	34	43	46	67	57	63	53	56	57	60	66
Amortization Expense	-	-	-	-	-	0.51	0.90	2.51	3.18	2.24	1.97
Non-Cash Adjustments To Reconcile Net Income	24	31	41	54	23	33	61	19	44	27	23
Changes in Operating Assets and Liabilities, net	-13	-54	-49	-48	-3.65	-65	20	-62	-67	-64	-53
Net Cash From Investing Activities	-62	-79	-65	-74	-57	-66	-9.26	-0.01	-53	-32	-41
Net Cash From Continuing Investing Activities	-62	-79	-65	-74	-57	-66	-9.26	-0.01	-53	-32	-41
Purchase of Property, Plant & Equipment	-40	-43	-15	-24	-13	-7.42	-0.70	-3.59	-8.42	-6.49	-8.43
Acquisitions	-5.42	-7.07	-6.70	-5.21	-8.70	-2.93	-1.90	-4.09	-20	-8.34	-8.45
Sale and/or Maturity of Investments	-	-	-	-	-	-15	0.00	18	0.00	1.05	0.00
Other Investing Activities, net	-17	-28	-43	-43	-35	-40	-6.65	-10	-25	-18	-24
Net Cash From Financing Activities	52	205	-126	-58	-71	-57	241	-133	-59	-49	-6.04
Net Cash From Continuing Financing Activities	52	205	-126	-58	-71	-57	241	-133	-59	-49	-6.04
Repayment of Debt	-1.22	-12	-20	-2.00	-53	-55	-1.07	-309	-5.88	-53	-43
Repurchase of Common Equity	-3.06	-51	-2.00	-46	-71	-22	-38	-24	-83	-27	-18
Payment of Dividends	0.00	-9.51	0.00	0.00	-6.93	-4.38	-4.21	-4.89	-2.70	-1.44	0.00
Issuance of Debt	4.71	25	0.00	0.00	65	35	288	227	38	40	55
Other Financing Activities, net	6.98	33	10	-4.26	-12	1.81	-0.51	-22	-4.64	-6.95	-0.20
Other Net Changes in Cash	-	-	-	-	-	-	-0.41	-1.01	2.17	0.50	0.81

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-23	10	1.85	-3.98	14	-33	4.82	11	13	-3.91	-3.52
Net Cash From Operating Activities	5.77	17	21	4.64	29	4.01	-11	35	35	11	6.95
Net Cash From Continuing Operating Activities	5.77	17	21	4.64	29	4.01	-11	35	35	11	6.95
Net Income / (Loss) Continuing Operations	-7.76	4.08	5.12	9.61	15	3.31	5.42	5.07	15	6.87	8.15
Consolidated Net Income / (Loss)	-7.76	4.08	5.12	9.61	15	3.31	5.42	5.07	15	6.87	8.15
Depreciation Expense	16	14	13	14	19	14	15	19	15	17	15
Amortization Expense	0.71	0.71	0.63	0.63	0.49	0.49	0.49	0.49	0.49	0.49	0.49
Non-Cash Adjustments To Reconcile Net Income	7.06	9.76	5.54	8.64	5.73	7.29	4.93	9.39	4.40	4.60	5.60
Changes in Operating Assets and Liabilities, net	-9.88	-12	-3.39	-28	-12	-21	-37	1.25	0.15	-17	-22
Net Cash From Investing Activities	-22	-13	-4.28	-4.24	-10	-13	-7.14	-8.50	-15	-11	-15
Net Cash From Continuing Investing Activities	-22	-13	-4.28	-4.24	-10	-13	-7.14	-8.50	-15	-11	-15
Purchase of Property, Plant & Equipment	-2.31	-3.18	-0.36	-0.65	-1.53	-3.95	-1.10	-1.59	-1.13	-4.61	-1.65
Acquisitions	-14	-4.45	-1.76	-1.72	-1.94	-2.93	-1.59	-1.60	-1.61	-3.65	-1.23
Other Investing Activities, net	-5.89	-5.26	-2.16	-1.88	-6.67	-7.30	-4.44	-5.32	-12	-2.61	-12
Net Cash From Financing Activities	-7.09	6.08	-15	-4.72	-4.59	-24	23	-16	-7.56	-5.09	4.23
Net Cash From Continuing Financing Activities	-7.09	6.08	-15	-4.72	-4.59	-24	23	-16	-7.56	-5.09	4.23
Repayment of Debt	-3.85	-0.00	-31	-7.71	-4.17	-10	-0.16	-21	-11	-10	-10
Repurchase of Common Equity	-5.43	-27	-3.66	-0.36	-0.25	-23	-18	-0.25	-	0.13	0.00
Issuance of Debt	4.89	33	26	5.00	0.32	8.69	45	6.00	4.00	-	23
Other Financing Activities, net	-	-0.35	-6.23	-0.23	-0.48	-0.01	-4.19	-0.78	-0.38	5.16	-8.56
Other Net Changes in Cash	0.76	0.21	-0.06	-	-	-0.10	0.13	-	-	-	-0.08

This table presents IMAX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	622	931	857	867	874	889	998	883	821	815	830
Total Current Assets	310	578	472	457	290	390	555	480	407	256	254
Cash & Equivalents	107	317	205	159	142	109	317	190	97	76	101
Accounts Receivable	182	215	218	260	93	100	56	110	136	136	108
Inventories, net	17	39	42	31	45	43	40	27	32	32	33
Prepaid Expenses	4.95	6.50	6.63	7.55	10	10	10	12	12	12	13
Plant, Property, & Equipment, net	183	218	245	277	281	307	277	260	253	243	240
Total Noncurrent Assets	128	134	140	133	303	192	165	143	161	315	336
Noncurrent Note & Lease Receivables	-	-	-	-	127	40	41	44	44	191	202
Goodwill	39	39	39	39	39	39	39	39	53	53	53
Intangible Assets	28	29	30	31	34	30	26	23	33	35	35
Noncurrent Deferred & Refundable Income Taxes	23	26	21	31	31	24	18	14	9.90	7.99	14
Other Noncurrent Operating Assets	38	41	50	32	70	43	27	22	21	28	31
Total Liabilities & Shareholders' Equity	622	931	857	867	874	889	998	883	821	815	830
Total Liabilities	195	253	231	263	274	246	533	453	491	469	452
Total Current Liabilities	190	224	203	238	130	133	208	128	143	137	173
Accounts Payable	26	23	20	24	32	20	21	16	25	26	20
Accrued Expenses	75	96	93	100	98	113	99	112	117	111	101
Current Deferred Revenue	89	105	90	113	-	-	88	-	-	-	53
Total Noncurrent Liabilities	4.71	29	27	25	144	113	325	325	349	332	279
Long-Term Debt	4.71	29	27	25	38	18	306	226	263	252	266
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	0.00	19	18	15	13	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Redeemable Noncontrolling Interest	44	3.31	4.98	1.35	6.44	5.91	0.76	0.76	0.72	0.66	0.68
Total Equity & Noncontrolling Interests	383	674	622	602	593	637	464	430	329	345	378
Total Preferred & Common Equity	383	624	562	528	512	548	394	356	263	273	299
Total Common Equity	383	624	562	528	512	548	394	356	263	273	299
Common Stock	392	611	617	621	602	595	596	585	562	574	587
Retained Earnings	-6.26	20	-47	-88	-85	-40	-203	-235	-293	-293	-275
Accumulated Other Comprehensive Income / (Loss)	-3.15	-7.44	-5.20	-0.63	-3.59	-3.19	0.99	2.53	-9.85	-12	-17
Other Equity Adjustments	-	-	-	-	-	-	0.00	3.93	3.93	3.93	4.05
Noncontrolling Interest	0.00	50	60	75	81	89	70	74	66	72	78

This table presents IMAX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	800	822	816	851	824	827	848	848
Total Current Assets	385	406	396	429	396	263	270	265
Cash & Equivalents	87	99	95	110	81	92	105	97
Accounts Receivable	126	123	126	136	141	122	114	122
Inventories, net	36	37	37	45	36	38	38	32
Prepaid Expenses	13	14	12	13	13	12	13	14
Plant, Property, & Equipment, net	252	248	239	238	240	238	245	245
Total Noncurrent Assets	164	168	181	184	188	327	333	338
Noncurrent Note & Lease Receivables	44	47	57	59	65	193	198	203
Goodwill	62	53	53	53	53	53	53	53
Intangible Assets	22	33	34	34	35	35	34	35
Noncurrent Deferred & Refundable Income Taxes	14	11	11	12	7.71	16	16	14
Other Noncurrent Operating Assets	21	22	24	25	28	30	32	33
Total Liabilities & Shareholders' Equity	800	822	816	851	824	827	848	848
Total Liabilities	462	488	478	494	491	484	480	464
Total Current Liabilities	142	213	141	228	120	189	191	118
Accounts Payable	23	26	24	38	19	20	26	25
Accrued Expenses	119	114	117	124	101	106	111	93
Total Noncurrent Liabilities	321	275	337	266	371	295	289	346
Long-Term Debt	229	259	256	252	297	283	276	280
Noncurrent Deferred Revenue	76	-	68	-	61	-	-	54
Noncurrent Deferred & Payable Income Tax Liabilities	15	16	14	13	13	13	13	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.74	0.73	0.73	0.66	0.65	0.66	0.67	0.68
Total Equity & Noncontrolling Interests	337	333	337	357	333	342	367	384
Total Preferred & Common Equity	273	264	271	287	259	267	289	300
Total Common Equity	273	264	271	287	259	267	289	300
Common Stock	569	560	566	570	565	571	577	584
Retained Earnings	-283	-292	-284	-272	-297	-294	-280	-272
Accumulated Other Comprehensive Income / (Loss)	-16	-7.88	-15	-15	-13	-14	-11	-16
Other Equity Adjustments	3.93	3.93	3.93	3.93	3.93	3.93	3.93	4.11
Noncontrolling Interest	64	69	66	70	74	75	78	84

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.90%	28.66%	0.94%	0.91%	-1.67%	5.68%	-65.37%	86.04%	18.02%	24.61%	-6.04%
EBITDA Growth	-10.06%	42.93%	-18.98%	-8.29%	4.48%	37.85%	-148.46%	201.32%	-20.42%	104.81%	-1.17%
EBIT Growth	-10.56%	52.28%	-32.29%	-48.53%	44.46%	72.97%	-257.64%	108.64%	-145.95%	1,142.57%	-12.97%
NOPAT Growth	-10.10%	56.12%	-37.57%	-67.16%	154.94%	70.12%	-241.94%	88.77%	64.66%	1,167.90%	5.30%
Net Income Growth	-4.41%	53.25%	-39.16%	-68.16%	168.37%	74.34%	-368.88%	93.92%	-107.55%	266.35%	-1.10%
EPS Growth	-12.50%	39.29%	-46.15%	-90.48%	800.00%	111.11%	-419.74%	84.36%	-5.26%	215.00%	4.35%
Operating Cash Flow Growth	57.91%	-3.11%	-7.52%	9.62%	28.82%	-17.82%	-125.46%	126.36%	185.59%	238.40%	20.85%
Free Cash Flow Firm Growth	903.56%	-58.79%	-617.39%	59.45%	251.94%	66.57%	-37.85%	-412.95%	10.55%	128.22%	72.59%
Invested Capital Growth	12.02%	19.73%	15.46%	4.71%	5.16%	8.42%	-18.04%	5.98%	6.16%	5.48%	4.30%
Revenue Q/Q Growth	-0.88%	4.73%	-3.19%	5.15%	-4.24%	4.03%	-33.26%	25.99%	-3.38%	-3.11%	1.93%
EBITDA Q/Q Growth	-7.48%	4.93%	-12.39%	24.59%	-24.17%	23.62%	-180.35%	171.16%	-26.33%	-4.63%	9.68%
EBIT Q/Q Growth	-13.52%	5.20%	-20.78%	17.27%	-31.94%	46.03%	-47.65%	136.10%	-136.45%	-8.69%	18.26%
NOPAT Q/Q Growth	-14.06%	7.04%	-26.04%	-20.73%	-28.70%	76.33%	-47.65%	53.07%	79.11%	-1.80%	8.53%
Net Income Q/Q Growth	-11.19%	6.13%	-26.49%	-21.25%	-12.79%	42.89%	-35.08%	77.47%	-87.89%	-2.28%	12.20%
EPS Q/Q Growth	-17.65%	4.00%	-31.15%	-55.56%	-12.20%	52.00%	-37.29%	58.70%	-48.15%	2.22%	9.09%
Operating Cash Flow Q/Q Growth	-7.48%	47.58%	-10.99%	-11.07%	22.17%	-17.21%	-198.88%	151.51%	-33.71%	-17.96%	11.80%
Free Cash Flow Firm Q/Q Growth	-56.49%	108.28%	-190.69%	-21.43%	160.36%	297.25%	23.67%	-209.14%	10.85%	-41.68%	459.80%
Invested Capital Q/Q Growth	10.31%	-2.64%	2.83%	2.18%	-2.18%	0.23%	-6.09%	1.43%	3.23%	4.26%	0.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.68%	58.66%	53.71%	48.65%	54.70%	53.52%	1.70%	52.73%	51.98%	57.18%	54.00%
EBITDA Margin	31.68%	35.19%	28.24%	25.67%	27.27%	35.58%	-49.79%	27.12%	18.29%	30.05%	31.61%
Operating Margin	19.92%	23.48%	15.53%	8.26%	12.07%	19.53%	-88.92%	4.31%	-1.61%	13.45%	12.45%
EBIT Margin	20.06%	23.74%	15.92%	8.12%	11.93%	19.53%	-88.92%	4.13%	-1.61%	13.45%	12.45%
Profit (Net Income) Margin	14.51%	17.29%	10.42%	3.29%	8.97%	14.80%	-114.95%	-3.76%	-6.61%	8.82%	9.28%
Tax Burden Percent	73.53%	74.21%	67.97%	41.71%	77.04%	77.75%	121.96%	-87.17%	203.47%	71.70%	86.75%
Interest Burden Percent	98.41%	98.13%	96.28%	97.04%	97.60%	97.49%	105.99%	104.43%	202.09%	91.51%	85.95%
Effective Tax Rate	25.22%	23.03%	28.02%	55.95%	21.83%	22.26%	0.00%	187.17%	0.00%	28.30%	13.25%
Return on Invested Capital (ROIC)	14.07%	18.93%	10.06%	3.01%	7.32%	11.66%	-17.48%	-2.12%	-0.70%	7.11%	7.14%
ROIC Less NNEP Spread (ROIC-NNEP)	15.76%	20.43%	11.29%	3.87%	8.77%	13.08%	91.70%	-2.17%	-17.21%	5.31%	4.01%
Return on Net Nonoperating Assets (RNNOA)	-2.77%	-7.22%	-4.03%	-0.98%	-1.74%	-2.23%	-10.95%	-0.02%	-4.52%	2.68%	1.89%
Return on Equity (ROE)	11.30%	11.71%	6.03%	2.04%	5.59%	9.43%	-28.43%	-2.14%	-5.23%	9.79%	9.04%
Cash Return on Invested Capital (CROIC)	2.74%	0.97%	-4.28%	-1.58%	2.29%	3.57%	2.35%	-7.92%	-6.68%	1.78%	2.93%
Operating Return on Assets (OROA)	10.57%	11.43%	6.72%	3.59%	5.13%	8.77%	-12.91%	1.12%	-0.57%	6.16%	5.33%
Return on Assets (ROA)	7.65%	8.33%	4.40%	1.45%	3.86%	6.65%	-16.69%	-1.02%	-2.33%	4.04%	3.98%
Return on Common Equity (ROCE)	10.64%	10.68%	5.49%	1.80%	4.83%	8.04%	-24.17%	-1.79%	-4.26%	7.78%	7.15%
Return on Equity Simple (ROE_SIMPLE)	11.02%	10.36%	7.00%	2.37%	6.56%	10.69%	-39.97%	-2.69%	-7.55%	12.11%	10.92%
Net Operating Profit after Tax (NOPAT)	43	68	42	14	35	60	-85	-9.57	-3.38	36	38
NOPAT Margin	14.89%	18.07%	11.18%	3.64%	9.43%	15.18%	-62.24%	-3.76%	-1.12%	9.64%	10.80%
Net Nonoperating Expense Percent (NNEP)	-1.68%	-1.51%	-1.23%	-0.86%	-1.44%	-1.42%	-109.18%	0.05%	16.50%	1.80%	3.13%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-0.57%	6.05%	5.91%
Cost of Revenue to Revenue	40.32%	41.34%	46.29%	51.35%	45.30%	46.48%	98.30%	45.72%	48.02%	42.82%	46.00%
SG&A Expenses to Revenue	32.10%	30.86%	32.95%	28.86%	31.38%	31.20%	79.18%	46.03%	45.89%	38.52%	37.68%
R&D to Revenue	5.54%	3.41%	4.32%	5.48%	3.67%	1.32%	4.10%	2.72%	1.76%	2.70%	1.45%
Operating Expenses to Revenue	39.76%	35.18%	38.18%	40.39%	42.63%	33.98%	91.06%	49.97%	53.59%	43.74%	41.55%
Earnings before Interest and Taxes (EBIT)	58	89	60	31	45	77	-122	11	-4.83	50	44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	92	132	107	98	102	141	-68	69	55	113	111
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.53	3.94	3.73	2.84	2.30	2.29	2.69	2.96	3.12	3.00	4.50
Price to Tangible Book Value (P/TBV)	6.70	4.42	4.26	3.28	2.68	2.62	3.23	3.59	4.62	4.43	6.38
Price to Revenue (P/Rev)	7.29	6.58	5.56	3.94	3.14	3.16	7.74	4.14	2.73	2.19	3.83
Price to Earnings (P/E)	53.28	44.04	72.88	639.54	51.53	26.72	0.00	0.00	0.00	32.37	51.75
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.88%	2.27%	1.37%	0.16%	1.94%	3.74%	0.00%	0.00%	0.00%	3.09%	1.93%
Enterprise Value to Invested Capital (EV/IC)	6.34	5.72	4.42	3.07	2.34	2.31	2.52	2.50	2.13	2.05	2.93
Enterprise Value to Revenue (EV/Rev)	7.09	5.95	5.26	3.79	3.10	3.14	8.07	4.57	3.50	2.85	4.52
Enterprise Value to EBITDA (EV/EBITDA)	22.38	16.91	18.63	14.75	11.36	8.81	0.00	16.84	19.12	9.48	14.31
Enterprise Value to EBIT (EV/EBIT)	35.34	25.07	33.04	46.61	25.95	16.05	0.00	110.60	0.00	21.20	36.32
Enterprise Value to NOPAT (EV/NOPAT)	47.59	32.92	47.07	104.07	32.83	20.65	0.00	0.00	0.00	29.57	41.87
Enterprise Value to Operating Cash Flow (EV/OCF)	23.70	26.41	25.49	16.89	10.54	13.73	0.00	191.86	60.71	18.23	22.49
Enterprise Value to Free Cash Flow (EV/FCFF)	244.64	641.10	0.00	0.00	104.85	67.35	96.61	0.00	0.00	118.11	102.04
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.04	0.04	0.04	0.06	0.03	0.66	0.53	0.80	0.73	0.70
Long-Term Debt to Equity	0.01	0.04	0.04	0.04	0.06	0.03	0.66	0.53	0.80	0.73	0.70
Financial Leverage	-0.18	-0.35	-0.36	-0.25	-0.20	-0.17	-0.12	0.01	0.26	0.50	0.47
Leverage Ratio	1.48	1.41	1.37	1.40	1.45	1.42	1.70	2.10	2.24	2.42	2.27
Compound Leverage Factor	1.45	1.38	1.32	1.36	1.41	1.38	1.81	2.19	4.53	2.22	1.95
Debt to Total Capital	1.09%	4.14%	4.18%	4.03%	5.93%	2.76%	39.68%	34.44%	44.37%	42.17%	41.31%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	1.09%	4.14%	4.18%	4.03%	5.93%	2.76%	39.68%	34.44%	44.37%	42.17%	41.31%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	10.18%	7.54%	9.87%	12.06%	13.69%	14.43%	9.18%	11.32%	11.20%	12.12%	12.22%
Common Equity to Total Capital	88.73%	88.32%	85.95%	83.91%	80.39%	82.82%	51.14%	54.24%	44.43%	45.70%	46.47%
Debt to EBITDA	0.05	0.22	0.26	0.26	0.37	0.13	-4.48	3.27	4.78	2.24	2.39
Net Debt to EBITDA	-1.11	-2.19	-1.67	-1.36	-1.03	-0.76	0.37	0.51	2.99	1.56	1.49
Long-Term Debt to EBITDA	0.05	0.22	0.26	0.26	0.37	0.13	-4.48	3.27	4.78	2.24	2.39
Debt to NOPAT	0.11	0.43	0.65	1.83	1.07	0.30	-3.58	-23.62	-77.73	6.98	7.00
Net Debt to NOPAT	-2.35	-4.27	-4.21	-9.63	-2.97	-1.78	0.30	-3.69	-48.64	4.87	4.35
Long-Term Debt to NOPAT	0.11	0.43	0.65	1.83	1.07	0.30	-3.58	-23.62	-77.73	6.98	7.00
Altman Z-Score	7.51	7.02	6.42	4.14	3.26	4.07	1.06	1.83	1.24	1.39	2.04
Noncontrolling Interest Sharing Ratio	5.88%	8.80%	9.04%	11.41%	13.55%	14.70%	15.00%	16.20%	18.51%	20.56%	20.89%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	2.58	2.32	1.92	2.23	2.93	2.67	3.75	2.85	1.87	1.47
Quick Ratio	1.52	2.38	2.08	1.76	1.81	2.53	2.43	3.45	2.55	1.55	1.20
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	8.42	3.47	-18	-7.28	11	18	11	-36	-32	9.05	16
Operating Cash Flow to CapEx	216.70%	194.66%	509.70%	353.58%	822.65%	1,217.84%	-3,301.43%	168.94%	205.61%	903.02%	840.50%
Free Cash Flow to Firm to Interest Expense	9.11	2.09	-8.04	-3.75	3.79	5.22	1.63	-5.05	-4.98	1.25	1.84
Operating Cash Flow to Interest Expense	94.05	50.70	34.86	43.96	37.71	25.60	-3.28	0.86	2.69	8.11	8.36
Operating Cash Flow Less CapEx to Interest Expense	50.65	24.65	28.02	31.53	33.13	23.50	-3.38	0.35	1.38	7.21	7.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.48	0.42	0.44	0.43	0.45	0.15	0.27	0.35	0.46	0.43
Accounts Receivable Turnover	1.61	1.88	1.74	1.59	2.12	4.10	1.76	3.06	2.44	2.75	2.89
Inventory Turnover	8.71	5.54	4.32	5.36	4.50	4.20	3.26	3.50	4.94	5.09	5.03
Fixed Asset Turnover	1.84	1.86	1.63	1.46	1.34	1.35	0.47	0.95	1.17	1.51	1.46
Accounts Payable Turnover	5.14	6.23	8.04	8.84	6.03	7.01	6.53	6.34	7.02	6.22	7.02
Days Sales Outstanding (DSO)	227.35	193.81	209.76	229.35	172.24	88.94	207.56	119.11	149.37	132.63	126.39
Days Inventory Outstanding (DIO)	41.89	65.92	84.51	68.05	81.08	86.87	111.89	104.16	73.86	71.77	72.57
Days Payable Outstanding (DPO)	70.94	58.58	45.40	41.28	60.57	52.07	55.90	57.60	52.03	58.70	52.03
Cash Conversion Cycle (CCC)	198.29	201.15	248.87	256.12	192.74	123.75	263.55	165.66	171.20	145.70	146.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	325	389	449	470	494	536	439	466	494	521	544
Invested Capital Turnover	0.95	1.05	0.90	0.83	0.78	0.77	0.28	0.56	0.63	0.74	0.66
Increase / (Decrease) in Invested Capital	35	64	60	21	24	42	-97	26	29	27	22
Enterprise Value (EV)	2,059	2,224	1,985	1,442	1,160	1,241	1,106	1,164	1,052	1,069	1,593
Market Capitalization	2,117	2,459	2,098	1,499	1,177	1,252	1,061	1,054	821	820	1,349
Book Value per Share	$5.59	$9.02	$8.41	$8.15	$8.18	$8.94	$6.69	$6.03	$4.71	$5.00	$5.68
Tangible Book Value per Share	$4.61	$8.03	$7.37	$7.07	$7.02	$7.80	$5.58	$4.98	$3.18	$3.39	$4.02
Total Capital	431	706	654	629	637	661	770	656	593	598	644
Total Debt	4.71	29	27	25	38	18	306	226	263	252	266
Total Long-Term Debt	4.71	29	27	25	38	18	306	226	263	252	266
Net Debt	-102	-288	-177	-133	-105	-107	-25	35	165	176	166
Capital Expenditures (CapEx)	40	43	15	24	13	7.42	0.70	3.59	8.42	6.49	8.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	14	36	64	61	18	148	30	162	167	43	-20
Debt-free Net Working Capital (DFNWC)	120	354	269	219	160	257	347	352	264	119	81
Net Working Capital (NWC)	120	354	269	219	160	257	347	352	264	119	81
Net Nonoperating Expense (NNE)	1.10	2.94	2.86	1.33	1.72	1.51	72	0.00	16	3.07	5.35
Net Nonoperating Obligations (NNO)	-102	-288	-177	-133	-105	-107	-25	35	165	176	166
Total Depreciation and Amortization (D&A)	34	43	46	67	57	63	54	59	60	62	67
Debt-free, Cash-free Net Working Capital to Revenue	4.69%	9.70%	16.90%	15.95%	4.91%	37.30%	21.85%	63.55%	55.48%	11.42%	-5.61%
Debt-free Net Working Capital to Revenue	41.35%	94.63%	71.16%	57.64%	42.73%	64.97%	253.51%	137.98%	87.86%	31.74%	22.95%
Net Working Capital to Revenue	41.35%	94.63%	71.16%	57.64%	42.73%	64.97%	253.51%	137.98%	87.86%	31.74%	22.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.58	$0.79	$0.43	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.47	$0.49
Adjusted Weighted Average Basic Shares Outstanding	68.99M	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	56.67M	54.31M	52.65M
Adjusted Diluted Earnings per Share	$0.56	$0.78	$0.42	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.46	$0.48
Adjusted Weighted Average Diluted Shares Outstanding	68.99M	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	56.67M	55.15M	53.86M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.76	($2.43)	($0.38)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	68.99M	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	53.97M	52.95M	53.02M
Normalized Net Operating Profit after Tax (NOPAT)	46	68	42	34	52	61	-82	6.45	-0.25	38	41
Normalized NOPAT Margin	15.80%	18.24%	11.26%	8.98%	13.88%	15.35%	-59.56%	2.53%	-0.08%	10.23%	11.73%
Pre Tax Income Margin	19.74%	23.30%	15.33%	7.88%	11.65%	19.04%	-94.25%	4.31%	-3.25%	12.30%	10.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	63.07	53.43	26.90	15.92	15.32	21.89	-17.38	1.48	-0.75	6.97	5.18
NOPAT to Interest Expense	46.83	40.67	18.88	7.13	12.11	17.02	-12.16	-1.35	-0.53	5.00	4.49
EBIT Less CapEx to Interest Expense	19.67	27.38	20.06	3.49	10.74	19.79	-17.48	0.98	-2.06	6.07	4.18
NOPAT Less CapEx to Interest Expense	3.43	14.63	12.04	-5.30	7.53	14.92	-12.26	-1.86	-1.84	4.10	3.50
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	14.72%	0.00%	0.00%	20.64%	7.48%	-2.68%	-51.05%	-13.60%	4.35%	0.00%
Augmented Payout Ratio	7.26%	92.91%	5.08%	368.59%	233.41%	44.74%	-26.91%	-301.28%	-432.01%	85.51%	54.95%

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.47%	-9.69%	44.82%	32.46%	51.11%	-12.27%	-9.00%	-9.20%	-11.98%	7.74%	9.53%
EBITDA Growth	-18.38%	-46.92%	342.18%	92.15%	249.11%	-24.59%	8.96%	-22.88%	-16.74%	58.57%	16.12%
EBIT Growth	-351.34%	-70.60%	241.94%	14,107.92%	603.24%	-63.66%	4.90%	-80.46%	-11.90%	247.28%	39.33%
NOPAT Growth	-396.83%	-63.93%	203.80%	14,894.96%	617.02%	23.06%	5.93%	29.45%	9.59%	26.40%	42.92%
Net Income Growth	-22.27%	-69.50%	142.87%	326.14%	293.62%	-18.87%	5.80%	-47.23%	2.16%	107.37%	50.37%
EPS Growth	-14.29%	-76.47%	117.39%	400.00%	237.50%	25.00%	50.00%	-53.33%	18.18%	80.00%	-33.33%
Operating Cash Flow Growth	325.02%	-34.34%	660.88%	407.09%	397.97%	-76.21%	-151.69%	655.62%	22.71%	186.62%	163.38%
Free Cash Flow Firm Growth	-376.64%	-92.48%	74.72%	17.35%	73.82%	11.61%	-390.73%	-51.15%	-279.84%	30.13%	84.18%
Invested Capital Growth	4.30%	6.16%	3.43%	5.50%	4.44%	5.48%	11.73%	7.43%	7.88%	4.30%	3.09%
Revenue Q/Q Growth	-7.05%	42.60%	-11.32%	12.69%	6.04%	-17.21%	-8.02%	12.43%	2.80%	1.33%	-6.48%
EBITDA Q/Q Growth	-19.70%	85.79%	13.93%	13.04%	45.90%	-59.87%	64.61%	-19.99%	57.51%	-23.56%	20.54%
EBIT Q/Q Growth	-4,234.65%	272.16%	51.27%	24.09%	55.73%	-87.57%	336.66%	-76.88%	602.03%	-51.00%	75.19%
NOPAT Q/Q Growth	-4,096.04%	270.03%	15.70%	79.23%	46.63%	-59.53%	-0.40%	119.02%	24.13%	-53.32%	12.62%
Net Income Q/Q Growth	-82.47%	152.61%	25.53%	87.64%	56.24%	-77.95%	63.70%	-6.40%	202.44%	-55.25%	18.70%
EPS Q/Q Growth	-220.00%	125.00%	0.00%	275.00%	46.67%	-77.27%	20.00%	16.67%	271.43%	-65.38%	-55.56%
Operating Cash Flow Q/Q Growth	482.38%	191.65%	26.00%	-78.15%	520.08%	-86.06%	-373.72%	419.46%	0.70%	-67.45%	-39.48%
Free Cash Flow Firm Q/Q Growth	-21.29%	-3.99%	55.55%	-47.42%	61.58%	-251.12%	-146.78%	54.60%	3.45%	35.41%	44.13%
Invested Capital Q/Q Growth	1.59%	3.23%	-0.45%	1.06%	0.57%	4.26%	5.44%	-2.83%	0.99%	0.80%	4.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.11%	57.31%	57.31%	59.08%	60.36%	51.05%	59.26%	49.38%	55.79%	52.19%	61.36%
EBITDA Margin	17.42%	22.69%	29.15%	29.24%	40.24%	19.50%	34.90%	24.84%	38.06%	28.71%	37.00%
Operating Margin	-6.16%	7.69%	13.11%	14.52%	21.21%	3.18%	15.25%	3.23%	21.23%	10.26%	19.31%
EBIT Margin	-6.37%	7.69%	13.11%	14.44%	21.21%	3.18%	15.12%	3.11%	21.23%	10.26%	19.23%
Profit (Net Income) Margin	-11.28%	4.16%	5.89%	9.81%	14.46%	3.85%	6.85%	5.70%	16.78%	7.41%	9.40%
Tax Burden Percent	143.41%	66.92%	51.19%	73.53%	69.62%	226.63%	51.23%	471.47%	86.59%	82.48%	52.80%
Interest Burden Percent	123.55%	80.91%	87.78%	92.41%	97.92%	53.34%	88.45%	38.92%	91.28%	87.51%	92.62%
Effective Tax Rate	0.00%	33.08%	48.81%	26.47%	30.38%	-126.63%	48.77%	-371.47%	13.41%	17.52%	47.20%
Return on Invested Capital (ROIC)	-2.86%	3.22%	4.55%	7.75%	11.67%	5.33%	5.50%	10.56%	12.22%	5.60%	6.57%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.20%	2.26%	3.90%	7.13%	11.44%	3.62%	5.10%	5.74%	11.29%	5.02%	6.23%
Return on Net Nonoperating Assets (RNNOA)	-1.94%	0.59%	1.15%	2.80%	4.67%	1.83%	2.86%	2.96%	4.89%	2.37%	3.46%
Return on Equity (ROE)	-4.81%	3.82%	5.69%	10.55%	16.34%	7.15%	8.37%	13.52%	17.11%	7.97%	10.03%
Cash Return on Invested Capital (CROIC)	-7.67%	-6.68%	-4.26%	-2.58%	3.17%	1.78%	-4.07%	-0.76%	-0.83%	2.93%	4.19%
Operating Return on Assets (OROA)	-2.37%	2.71%	5.14%	6.28%	9.94%	1.46%	6.74%	1.35%	8.64%	4.40%	8.27%
Return on Assets (ROA)	-4.20%	1.47%	2.31%	4.27%	6.77%	1.76%	3.06%	2.48%	6.83%	3.17%	4.05%
Return on Common Equity (ROCE)	-3.87%	3.11%	4.59%	8.51%	13.16%	5.68%	6.56%	10.69%	13.60%	6.30%	7.80%
Return on Equity Simple (ROE_SIMPLE)	-3.87%	0.00%	-1.06%	4.09%	11.79%	0.00%	12.89%	10.79%	10.07%	0.00%	11.83%
Net Operating Profit after Tax (NOPAT)	-2.97	5.04	5.84	10	15	6.21	6.18	14	17	7.85	8.84
NOPAT Margin	-4.31%	5.14%	6.71%	10.68%	14.76%	7.22%	7.81%	15.22%	18.38%	8.47%	10.20%
Net Nonoperating Expense Percent (NNEP)	5.33%	0.96%	0.65%	0.62%	0.22%	1.70%	0.41%	4.82%	0.93%	0.57%	0.34%
Return On Investment Capital (ROIC_SIMPLE)	-	0.85%	-	-	-	1.04%	-	-	-	1.22%	1.33%
Cost of Revenue to Revenue	55.07%	41.87%	42.69%	40.92%	39.64%	48.95%	40.78%	50.62%	44.21%	47.77%	38.64%
SG&A Expenses to Revenue	47.86%	38.62%	39.28%	39.71%	34.92%	40.77%	39.50%	42.23%	34.41%	34.98%	38.61%
R&D to Revenue	1.62%	1.66%	2.13%	2.82%	2.67%	3.16%	2.76%	2.28%	-0.29%	1.24%	1.52%
Operating Expenses to Revenue	51.10%	50.44%	44.20%	44.56%	39.16%	47.86%	43.97%	46.15%	34.56%	41.96%	42.19%
Earnings before Interest and Taxes (EBIT)	-4.38	7.54	11	14	22	2.74	12	2.77	19	9.51	17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	12	22	25	29	42	17	28	22	35	27	32
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.90	3.12	3.92	3.43	3.68	3.00	3.41	3.30	3.73	4.50	4.67
Price to Tangible Book Value (P/TBV)	4.18	4.62	5.82	5.04	5.28	4.43	5.16	4.92	5.34	6.38	6.60
Price to Revenue (P/Rev)	2.54	2.73	3.16	2.64	2.73	2.19	2.41	2.47	3.13	3.83	3.88
Price to Earnings (P/E)	0.00	0.00	0.00	207.72	41.53	32.37	33.76	41.26	46.38	51.75	55.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.48%	2.41%	3.09%	2.96%	2.42%	2.16%	1.93%	1.80%
Enterprise Value to Invested Capital (EV/IC)	2.08	2.13	2.57	2.32	2.54	2.05	2.14	2.15	2.47	2.93	2.94
Enterprise Value to Revenue (EV/Rev)	3.20	3.50	3.85	3.28	3.28	2.85	3.20	3.21	3.85	4.52	4.63
Enterprise Value to EBITDA (EV/EBITDA)	13.36	19.12	16.93	13.05	10.74	9.48	10.21	10.59	13.11	14.31	14.38
Enterprise Value to EBIT (EV/EBIT)	75.22	0.00	86.53	39.90	22.98	21.20	22.99	28.95	35.87	36.32	34.30
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	85.75	34.47	29.57	32.17	34.84	37.95	41.87	41.19
Enterprise Value to Operating Cash Flow (EV/OCF)	38.18	60.71	29.85	23.81	17.75	18.23	44.42	20.23	21.00	22.49	18.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	81.77	118.11	0.00	0.00	0.00	102.04	71.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.68	0.80	0.77	0.76	0.71	0.73	0.89	0.82	0.75	0.70	0.73
Long-Term Debt to Equity	0.68	0.80	0.77	0.76	0.71	0.73	0.89	0.82	0.75	0.70	0.73
Financial Leverage	0.24	0.26	0.29	0.39	0.41	0.50	0.56	0.52	0.43	0.47	0.56
Leverage Ratio	2.20	2.24	2.24	2.32	2.37	2.42	2.47	2.41	2.34	2.27	2.33
Compound Leverage Factor	2.72	1.81	1.96	2.15	2.33	1.29	2.18	0.94	2.14	1.99	2.16
Debt to Total Capital	40.41%	44.37%	43.65%	43.13%	41.39%	42.17%	47.15%	45.20%	42.90%	41.31%	42.12%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	40.41%	44.37%	43.65%	43.13%	41.39%	42.17%	47.15%	45.20%	42.90%	41.31%	42.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	11.39%	11.20%	11.79%	11.27%	11.54%	12.12%	11.82%	12.11%	12.16%	12.22%	12.77%
Common Equity to Total Capital	48.20%	44.43%	44.57%	45.60%	47.07%	45.70%	41.02%	42.69%	44.94%	46.47%	45.11%
Debt to EBITDA	3.07	4.78	3.47	2.90	2.14	2.24	2.59	2.61	2.72	2.39	2.42
Net Debt to EBITDA	1.89	2.99	2.12	1.81	1.21	1.56	1.88	1.76	1.69	1.49	1.58
Long-Term Debt to EBITDA	3.07	4.78	3.47	2.90	2.14	2.24	2.59	2.61	2.72	2.39	2.42
Debt to NOPAT	-14.15	-77.73	-60.51	19.02	6.86	6.98	8.15	8.57	7.88	7.00	6.92
Net Debt to NOPAT	-8.70	-48.64	-37.04	11.87	3.88	4.87	5.93	5.80	4.90	4.35	4.52
Long-Term Debt to NOPAT	-14.15	-77.73	-60.51	19.02	6.86	6.98	8.15	8.57	7.88	7.00	6.92
Altman Z-Score	1.27	1.29	1.50	1.54	1.66	1.19	1.47	1.15	1.48	1.91	2.05
Noncontrolling Interest Sharing Ratio	19.54%	18.51%	19.34%	19.29%	19.41%	20.56%	21.64%	20.96%	20.51%	20.89%	22.21%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.72	2.85	1.90	2.81	1.88	1.87	3.31	1.39	1.41	1.47	2.25
Quick Ratio	2.37	2.55	1.66	2.46	1.63	1.55	2.90	1.13	1.15	1.20	1.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-23	-24	-11	-15	-5.95	-21	-52	-23	-23	-15	-8.15
Operating Cash Flow to CapEx	249.52%	530.23%	5,829.12%	718.91%	1,876.83%	101.44%	-993.48%	2,209.21%	3,133.39%	249.02%	422.55%
Free Cash Flow to Firm to Interest Expense	-17.17	-13.11	-5.69	-8.62	-3.81	-10.27	-26.49	-10.25	-9.62	-7.70	-4.53
Operating Cash Flow to Interest Expense	4.36	9.35	11.51	2.58	18.43	1.97	-5.64	15.35	15.02	6.06	3.86
Operating Cash Flow Less CapEx to Interest Expense	2.62	7.58	11.31	2.22	17.45	0.03	-6.21	14.66	14.54	3.63	2.95
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.35	0.39	0.43	0.47	0.46	0.45	0.44	0.41	0.43	0.43
Accounts Receivable Turnover	2.99	2.44	2.80	2.83	2.96	2.75	2.78	2.90	2.76	2.89	2.74
Inventory Turnover	3.99	4.94	4.77	4.66	4.11	5.09	4.29	4.34	3.91	5.03	4.81
Fixed Asset Turnover	1.22	1.17	1.29	1.43	1.58	1.51	1.50	1.50	1.43	1.46	1.48
Accounts Payable Turnover	7.80	7.02	7.03	7.49	5.57	6.22	7.09	7.37	5.09	7.02	7.46
Days Sales Outstanding (DSO)	122.17	149.37	130.23	128.79	123.43	132.63	131.26	126.06	132.12	126.39	133.38
Days Inventory Outstanding (DIO)	91.48	73.86	76.51	78.37	88.81	71.77	85.16	84.19	93.47	72.57	75.88
Days Payable Outstanding (DPO)	46.82	52.03	51.94	48.70	65.52	58.70	51.48	49.50	71.77	52.03	48.96
Cash Conversion Cycle (CCC)	166.83	171.20	154.81	158.46	146.72	145.70	164.94	160.75	153.81	146.94	160.30
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	479	494	492	497	500	521	550	534	540	544	567
Invested Capital Turnover	0.66	0.63	0.68	0.73	0.79	0.74	0.70	0.69	0.66	0.66	0.64
Increase / (Decrease) in Invested Capital	20	29	16	26	21	27	58	37	39	22	17
Enterprise Value (EV)	998	1,052	1,263	1,154	1,268	1,069	1,174	1,150	1,331	1,593	1,664
Market Capitalization	792	821	1,035	927	1,055	820	883	882	1,080	1,349	1,397
Book Value per Share	$4.87	$4.71	$4.89	$4.96	$5.26	$5.00	$4.93	$5.08	$5.49	$5.68	$5.65
Tangible Book Value per Share	$3.38	$3.18	$3.30	$3.37	$3.66	$3.39	$3.26	$3.41	$3.84	$4.02	$3.99
Total Capital	567	593	592	594	610	598	631	626	644	644	664
Total Debt	229	263	259	256	252	252	297	283	276	266	280
Total Long-Term Debt	229	263	259	256	252	252	297	283	276	266	280
Net Debt	141	165	158	160	143	176	216	191	172	166	183
Capital Expenditures (CapEx)	2.31	3.18	0.36	0.65	1.53	3.95	1.10	1.59	1.13	4.61	1.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	156	167	93	160	92	43	195	-18	-26	-20	50
Debt-free Net Working Capital (DFNWC)	243	264	193	255	201	119	276	74	79	81	147
Net Working Capital (NWC)	243	264	193	255	201	119	276	74	79	81	147
Net Nonoperating Expense (NNE)	4.79	0.96	0.71	0.85	0.32	2.90	0.76	8.47	1.47	0.98	0.69
Net Nonoperating Obligations (NNO)	141	165	158	160	143	176	216	191	172	166	183
Total Depreciation and Amortization (D&A)	16	15	14	15	20	14	16	19	15	17	15
Debt-free, Cash-free Net Working Capital to Revenue	50.13%	55.48%	28.47%	45.52%	23.74%	11.42%	53.21%	-5.01%	-7.48%	-5.61%	13.99%
Debt-free Net Working Capital to Revenue	78.13%	87.86%	58.75%	72.60%	52.07%	31.74%	75.28%	20.56%	22.76%	22.95%	40.97%
Net Working Capital to Revenue	78.13%	87.86%	58.75%	72.60%	52.07%	31.74%	75.28%	20.56%	22.76%	22.95%	40.97%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.16)	$0.04	$0.05	$0.15	$0.22	$0.05	$0.06	$0.07	$0.26	$0.10	$0.04
Adjusted Weighted Average Basic Shares Outstanding	55.97M	56.67M	54.06M	54.59M	54.62M	54.31M	52.50M	52.63M	52.68M	52.65M	53.15M
Adjusted Diluted Earnings per Share	($0.16)	$0.04	$0.04	$0.15	$0.22	$0.05	$0.06	$0.07	$0.26	$0.09	$0.04
Adjusted Weighted Average Diluted Shares Outstanding	55.97M	56.67M	54.99M	55.32M	55.54M	55.15M	53.41M	53.43M	54.09M	53.86M	54.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.97M	53.97M	54.59M	54.62M	54.61M	52.95M	52.62M	52.68M	52.68M	53.02M	53.74M
Normalized Net Operating Profit after Tax (NOPAT)	-2.97	5.04	6.53	10	15	3.03	6.18	2.01	17	11	8.87
Normalized NOPAT Margin	-4.31%	5.14%	7.51%	10.68%	14.76%	3.53%	7.81%	2.26%	18.38%	11.80%	10.23%
Pre Tax Income Margin	-7.87%	6.22%	11.51%	13.34%	20.77%	1.70%	13.37%	1.21%	19.38%	8.98%	17.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.31	4.18	6.18	7.88	14.12	1.35	6.15	1.21	8.26	5.02	9.25
NOPAT to Interest Expense	-2.24	2.80	3.16	5.83	9.83	3.05	3.18	5.93	7.16	4.14	4.91
EBIT Less CapEx to Interest Expense	-5.06	2.42	5.99	7.52	13.14	-0.60	5.58	0.52	7.78	2.59	8.34
NOPAT Less CapEx to Interest Expense	-3.99	1.04	2.97	5.47	8.85	1.11	2.61	5.24	6.68	1.71	3.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-24.23%	-13.60%	0.00%	37.45%	4.26%	4.35%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-695.02%	-432.01%	-2,806.95%	362.76%	95.30%	85.51%	123.00%	142.00%	139.56%	54.95%	0.32%

Frequently Asked Questions About IMAX's Financials

When does IMAX's financial year end?

According to the most recent income statement we have on file, IMAX's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has IMAX's net income changed over the last 10 years?

IMAX's net income appears to be on a downward trend, with a most recent value of $32.70 million in 2024, falling from $42.17 million in 2014. The previous period was $33.07 million in 2023. See where experts think IMAX is headed by visiting IMAX's forecast page.

What is IMAX's operating income?

IMAX's total operating income in 2024 was $43.86 million, based on the following breakdown:

Total Gross Profit: $190.20 million
Total Operating Expenses: $146.34 million

How has IMAX revenue changed over the last 10 years?

Over the last 10 years, IMAX's total revenue changed from $290.54 million in 2014 to $352.21 million in 2024, a change of 21.2%.

How much debt does IMAX have?

IMAX's total liabilities were at $452.18 million at the end of 2024, a 3.6% decrease from 2023, and a 132.1% increase since 2014.

How much cash does IMAX have?

In the past 10 years, IMAX's cash and equivalents has ranged from $76.20 million in 2023 to $317.45 million in 2015, and is currently $100.59 million as of their latest financial filing in 2024.

How has IMAX's book value per share changed over the last 10 years?

Over the last 10 years, IMAX's book value per share changed from 5.59 in 2014 to 5.68 in 2024, a change of 1.8%.

Related Companies

This page (NYSE:IMAX) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IMAX (IMAX) Financials

Frequently Asked Questions About IMAX's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IMAX (IMAX) Financials

Annual Income Statements for IMAX

Quarterly Income Statements for IMAX

Annual Cash Flow Statements for IMAX

Quarterly Cash Flow Statements for IMAX

Annual Balance Sheets for IMAX

Quarterly Balance Sheets for IMAX

Annual Metrics and Ratios for IMAX

Quarterly Metrics and Ratios for IMAX

Frequently Asked Questions About IMAX's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools